Sort by
Items per page

Send to

Choose Destination

Best matches for galectin-3 AND lungs OR galectin-3 AND asthma OR galectin-3 AND adenocarcinoma:

Search results

Items: 1 to 20 of 312


An orally active galectin-3 antagonist inhibits lung adenocarcinoma growth and augments response to PD-L1 blockade.

Vuong L, Kouverianou E, Rooney CM, McHugh BJ, Howie SE, Gregory CD, Forbes SJ, Henderson NC, Zetterberg FR, Nilsson UJ, Leffler H, Ford P, Pederson A, Gravelle L, Tantawi S, Schambye H, Sethi T, Mackinnon AC.

Cancer Res. 2019 Jan 23. pii: canres.2244.2018. doi: 10.1158/0008-5472.CAN-18-2244. [Epub ahead of print]


[Microcystic, elongated and fragmented invasion pattern in endometrial carcinoma: the clinicopathology analysis].

Zhang XB, Zhao CL, Qi XL, Qin Y, Wang Y, Shen DH.

Zhonghua Fu Chan Ke Za Zhi. 2018 Dec 25;53(12):811-815. doi: 10.3760/cma.j.issn.0529-567x.2018.12.003. Chinese.


Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancer.

Kataoka Y, Ohshio Y, Teramoto K, Igarashi T, Asai T, Hanaoka J.

Oncol Rep. 2019 Feb;41(2):853-862. doi: 10.3892/or.2018.6915. Epub 2018 Dec 7.


HH1-1, a novel Galectin-3 inhibitor, exerts anti-pancreatic cancer activity by blocking Galectin-3/EGFR/AKT/FOXO3 signaling pathway.

Yao Y, Zhou L, Liao W, Chen H, Du Z, Shao C, Wang P, Ding K.

Carbohydr Polym. 2019 Jan 15;204:111-123. doi: 10.1016/j.carbpol.2018.10.008. Epub 2018 Oct 5.


Diagnostic value of HBME-1, CK19, Galectin 3, and CD56 in the subtypes of follicular variant of papillary thyroid carcinoma.

Cho H, Kim JY, Oh YL.

Pathol Int. 2018 Nov;68(11):605-613. doi: 10.1111/pin.12729. Epub 2018 Oct 23.


Flavopiridol's effects on metastasis in KRAS mutant lung adenocarcinoma cells.

Dogan Turacli I, Demirtas Korkmaz F, Candar T, Ekmekci A.

J Cell Biochem. 2018 Oct 14. doi: 10.1002/jcb.27846. [Epub ahead of print]


Conventional Ultrasound, Immunohistochemical Factors and BRAFV600E Mutation in Predicting Central Cervical Lymph Node Metastasis of Papillary Thyroid Carcinoma.

Chen J, Li XL, Zhao CK, Wang D, Wang Q, Li MX, Wei Q, Ji G, Xu HX.

Ultrasound Med Biol. 2018 Nov;44(11):2296-2306. doi: 10.1016/j.ultrasmedbio.2018.06.020. Epub 2018 Aug 10.


Possible Autocrine Function of Galectin-3 in Pancreatic Stellate Cells.

Dash P, Minz AP, Senapati S.

Gastroenterology. 2018 Sep;155(3):933-934. doi: 10.1053/j.gastro.2018.01.076. Epub 2018 Aug 6. No abstract available.


A potential biomarker hsa-miR-200a-5p distinguishing between benign thyroid tumors with papillary hyperplasia and papillary thyroid carcinoma.

Wang X, Huang S, Li X, Jiang D, Yu H, Wu Q, Gao C, Wu Z.

PLoS One. 2018 Jul 13;13(7):e0200290. doi: 10.1371/journal.pone.0200290. eCollection 2018.


Galectin-3 activates TLR4/NF-κB signaling to promote lung adenocarcinoma cell proliferation through activating lncRNA-NEAT1 expression.

Zhou W, Chen X, Hu Q, Chen X, Chen Y, Huang L.

BMC Cancer. 2018 May 22;18(1):580. doi: 10.1186/s12885-018-4461-z.


Differential expression of PIWIL2 in papillary thyroid cancers.

Erdogdu IH, Yumrutas O, Ozgur Cevik M, Bozgeyik I, Erdogdu M, Inan HM, Bagis H.

Gene. 2018 Apr 5;649:8-13. doi: 10.1016/j.gene.2018.01.066. Epub 2018 Jan 31.


Expression and Distribution of Galectin-3 in Chromophobe and Papillary Carcinomas.

Cioca A, Muntean D, Bungardean C, Raica M, Cimpean AM.

Anticancer Res. 2018 Jan;38(1):259-263.


Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.

Zhao W, Ajani JA, Sushovan G, Ochi N, Hwang R, Hafley M, Johnson RL, Bresalier RS, Logsdon CD, Zhang Z, Song S.

Gastroenterology. 2018 Apr;154(5):1524-1537.e6. doi: 10.1053/j.gastro.2017.12.014. Epub 2017 Dec 21.


[The difference expression and diagnostic value of RPL5 in papillary thyroid carcinoma of children and adults].

Jin YQ, Wang SC, Tai J, Zhang J, Chen F, Shi J, Yu YB, Yang YR, Ren HM, Geng D, Liu YH, Guo YL, Ni X.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Nov 7;52(11):830-834. doi: 10.3760/cma.j.issn.1673-0860.2017.11.006. Chinese.


Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors.

Ajani JA, Estrella JS, Chen Q, Correa AM, Ma L, Scott AW, Jin J, Liu B, Xie M, Sudo K, Shiozaki H, Badgwell B, Weston B, Lee JH, Bhutani MS, Onodera H, Suzuki K, Suzuki A, Ding S, Hofstetter WL, Johnson RL, Bresalier RS, Song S.

Br J Cancer. 2018 Jan;118(1):52-61. doi: 10.1038/bjc.2017.388. Epub 2017 Nov 14.


Primary signet ring stromal tumor of the testis: a study of 13 cases indicating their phenotypic and genotypic analogy to pancreatic solid pseudopapillary neoplasm.

Michalova K, Michal M Jr, Kazakov DV, Sedivcova M, Hes O, Hadravsky L, Agaimy A, Tretiakova M, Bacchi C, Hartmann A, Kuroda N, Bulimbasic S, Coric M, Antic T, Michal M.

Hum Pathol. 2017 Sep;67:85-93. doi: 10.1016/j.humpath.2017.07.010. Epub 2017 Jul 21.


Galectin-1 is a diagnostic marker involved in thyroid cancer progression.

Arcolia V, Journe F, Wattier A, Leteurtre E, Renaud F, Gabius HJ, Remmelink M, Decaestecker C, Rodriguez A, Boutry S, Laurent S, Saussez S.

Int J Oncol. 2017 Sep;51(3):760-770. doi: 10.3892/ijo.2017.4065. Epub 2017 Jul 4.


Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.

Nigjeh EN, Chen R, Allen-Tamura Y, Brand RE, Brentnall TA, Pan S.

Proteomics Clin Appl. 2017 Sep;11(9-10). doi: 10.1002/prca.201700064. Epub 2017 Jul 10.


Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS).

Kim H, Yu SJ, Yeo I, Cho YY, Lee DH, Cho Y, Cho EJ, Lee JH, Kim YJ, Lee S, Jun J, Park T, Yoon JH, Kim Y.

Mol Cell Proteomics. 2017 Jul;16(7):1312-1323. doi: 10.1074/mcp.M116.066704. Epub 2017 May 26.

Supplemental Content

Loading ...
Support Center